Immune checkpoint inhibitors for treatment of periorbital squamous cell carcinoma.

Jeremy Allan GoldfarbRenata FerrarottoNeil GrossRyan GoepfertJames Matthew DebnamBrandon GunnPriyadharsini NagarajanBita Esmaeli

Published in: The British journal of ophthalmology (2021)

Our findings support the emerging role of anti-PD-1 immunotherapy in the management of locally advanced periorbital cutaneous squamous cell carcinoma.

Keyphrases

squamous cell carcinoma
locally advanced
neoadjuvant chemotherapy
rectal cancer
lymph node metastasis
phase ii study
radiation therapy
combination therapy
lymph node